Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN
Cleveland Clinic Taussig Cancer Institute
Dr. Beth Faiman received her bachelor of science in nursing and registered nurse certification at Ursuline College in Pepper Pike, Ohio. She received a master of science in nursing and certification as an adult nurse practitioner at Kent State University in Kent, Ohio, and a PhD in Clinical Research and Nursing from Case Western Reserve University. Dr. Faiman holds an advanced oncology nurse certification through Oncology Nursing Certification Corporation (ONCC). She is an Adult Nurse Practitioner in the Department of Hematologic Oncology and Blood Disorders at the Cleveland Clinic in Cleveland, Ohio, and adjunct faculty at Ursuline College, Case Western Reserve University and Kent State University.
Dr. Faiman is an active author, presenter, and educator on the topic of multiple myeloma, amyloidosis, chronic lymphocytic leukemia, plasma cell dyscrasias, general cancer diagnosis and treatment, as well as management of skeletal and other cancer complications. She is a founding member of the International Myeloma Foundation Nurse Leadership Board and recently appointed to serve on the Hematology Specialty Board (HSB) in the ASH Maintenance of Certification (MOC) Working Group. Dr. Faiman is currently editor-in-chief of The Oncology Nurse APN/PA, and is on the editorial board of ASH Clinical News, among others. She has edited several books, authored many chapters, and written numerous articles relating to the diagnosis and treatment of multiple myeloma, treatment adherence, pain, palliation, and cancer symptom management.
Dr. Faiman received the 2015 Dean’s Legacy Award for PhD Studies from Case Western Reserve University, and was named the Leukemia and Lymphoma Society’s Woman of the Year for Cleveland and Akron Ohio, 2016.
Ms. Beth Faiman has received consultant fees from Celgene Corporation and Millennium Pharmaceuticals, Inc.